On the other hand, the expression of DARPP-32 exhibits decreases in the post-mortem brain of patients with schizophrenia [59] and in the leukocytes of patients with schizophrenia and bipolar disorder [60]. This evidence concerns the gene PPP1R1B and bipolar disorder.